Advertisement
New options reduce medication burden.
By Michael Hopen, MD, Mark J. Gallardo, MD
Team glaucoma has acquired new players.
By Savak “Sev” Teymoorian, MD, MBA
A Q&A with 2 self-taught MIGS specialists.
By Nathan M. Radcliffe, MD, Blake K. Williamson, MD, MPH, MS, Michael Patterson, DO
A cost-conscious solution to ab interno trabeculectomy with pristine angle view.
By Hamed Esfandiari, MD, Nils Loewen, MD, PhD
What new drugs will mean to glaucoma specialists and patients.
By JOHN BERDAHL, MD, MICHAEL GREENWOOD, MD, Russell Swan, MD
Myths About Selective Laser Trabeculoplasty
By Nathan M. Radcliffe, MD, Inder Paul Singh, MD
Device Targets the Conventional Outflow Pathway
By Karen Appold, contributing writer